Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, New York 10065
Email Address: email@example.com
Founded in 1884 as the New York Cancer Hospital, Memorial Sloan-Kettering Cancer Center is the largest and oldest private cancer center in the world. Memorial Sloan Kettering Cancer Center (MSKCC) had more than 9,000 employees working with thousands of patients each year. In 2006 alone, MSKCC admitted more than 21,000 patients and accommodated more than 431,160 outpatient visits at its regional and Manhattan sites combined. Memorial Sloan-Kettering Cancer Center is also one of 39 National Cancer Institute-designated Comprehensive Cancer Centers.
The Disease Management Program at MSKCC features 16 multidisciplinary cancer teams made up of surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists as well as psychiatrists and nurses. Memorial Sloan-Kettering Cancer Center physicians treat more than 400 different subtypes of cancer each year. While MSKCC is known for its advanced, innovative therapies, Memorial Sloan physicians are also known for their care, compassion, and concern.
As a leader in cancer research, Memorial Sloan-Kettering Cancer Center features innovative programs in basic, translational, and clinical research. Research at MSKCC is dedicated to understanding the biology of cancer through programs in cell biology, genetics, biochemistry, molecular biology, structural biology, computational biology, immunology, and therapeutics. Memorial Sloan-Kettering Cancer Center investigators collaborate with Memorial Hospital physician-scientists, and it also actively initiates and participates in clinical trials. MSKCC physicians are currently leading more than 400 clinical trials for pediatric and adult cancers in an effort to identify more effective cancer therapies.
While Memorial Sloan-Kettering Cancer Center treats all types of cancer, MSKCC is one of the leading cancer centers in the U.S. for the treatment of mesothelioma. Memorial Sloan-Kettering Cancer Center offers the most effective and advanced treatments for this type of cancer, and it was among the first cancer centers to use intensity-modulated radiation therapy, or IMRT, for mesothelioma patients with unresectable disease. IMRT allows radiation to target the pleura, sparing surrounding healthy tissue and organs, such as the lung.
MSKCC has pioneered numerous new treatments for mesothelioma, and it has also established the nation’s largest database of mesothelioma patients whose treatment is continually tracked and analyzed. MSKCC’s team of surgical oncologists, medical oncologists, radiation oncologists, and thoracic pathologists work together to individualize treatment for each cancer patient.
MSKCC surgeons have extensive experience performing extrapleural pneumonectomy — a technically complicated surgical procedure and it has also created a Mesothelioma Working Group that features experts (in their respective fields) that share information on research and treatment advances.